Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units
Open Access
- 1 January 2016
- journal article
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 23, 191
Abstract
This study aims to determine the Acinetobacter sp clinical isolates frequency and its antibiotic susceptibility pattern by comparing results obtained from the Intensive Care Units (ICUs) to that of other units at the Mohammed V Military Teaching Hospital in Rabat. This is a retrospective study over a 2-years period where we collected all clinical isolates of Acinetobacter sp obtained from samples for infection diagnosis performed on hospitalized patients between 2012 to 2014. During the study period, 441 clinical and non-repetitive isolates of Acinetobacter sp were collected representing 6.94% of all bacterial clinical isolates (n = 6352) and 9.6% of Gram negative rods (n = 4569). More than a half of the isolates were from the ICUs and were obtained from 293 infected patients of which 65, 2% (191 cases) were males (sex ratio = 1.9) and the median age was 56 years (interquartile range: 42-68 years). Acinetobacter clinical isolates were obtained from respiratory samples (44.67%) followed by blood cultures (14.51%). The resistance to ciprofloxacin, ceftazidime, piperacillin / tazobactam, imipenem, amikacin, tobramycin, netilmicin, rifampicin and colistin was respectively 87%, 86%, 79%, 76%; 52%, 43%, 33% 32% and 1.7%. The difference in resistance between the ICUs and the other units was statistically significant (p <0.05) except for colistin, tetracycline and rifampicin. This paper shows that solving the problem of prevalence and high rate of multidrug resistant Acinetobacter infection which represents a therapeutic impasse, requires the control of the hospital environment and optimizing hands hygiene and antibiotics use in the hospital.Keywords
This publication has 26 references indexed in Scilit:
- Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients' respiratory tract sourcesAmerican Journal of Infection Control, 2014
- Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: Risk factors, clinical features, and outcomesAmerican Journal of Infection Control, 2014
- ICU-Associated Acinetobacter baumannii Colonisation/Infection in a High HIV-Prevalence Resource-Poor SettingPLOS ONE, 2012
- Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in childrenInternational Journal of Infectious Diseases, 2012
- Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortalityJournal of Critical Care, 2011
- High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimenDiagnostic Microbiology and Infectious Disease, 2011
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- Épidémiologie et profil de sensibilité des isolats d’hémoculture dans un service de réanimation (2002–2005)Medecine Et Maladies Infectieuses, 2008
- Prévalence et état de sensibilité aux antibiotiques d'Acinetobacter baumannii dans un CHU marocainMedecine Et Maladies Infectieuses, 2007
- An Outbreak Due to MultiresistantAcinetobacter baumanniiin a Burn Unit: Risk Factors for Acquisition and ManagementInfection Control & Hospital Epidemiology, 2002